Fact Checking the Fact Checkers: The Case of Ivermectin for Publicly-Subsidized Research

Fact Checking the Fact Checkers The Case of Ivermectin for Publicly-Subsidized Research

On December 11, TrialSite reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for ivermectin as both a prophylactic against and an early treatment for COVID-19. As we recently covered, there is mounting evidence in support of these uses, and definitely for government-sponsored research, for this cheap and safe drug. One media account we did not address was a December 10 “fact check” by the Associated Press (AP) in collaboration with Facebook titled, “No evidence ivermectin is a miracle drug against COVID-19.” In this piece, the AP relies on old protocols and also ignores newer evidence, showing an excessive deference to official edicts over honestly looking at the medical evidence. The AP author doesn’t do her homework as is elaborated on below. Based on accumulating data and growing evidence, the case for publicly-funded investigation into ivermectin is compelling. Does AP represent a particular agenda in that particular piece? Does power, politics, and money influence which research gets funded in the midst of the pandemic?

Errors in Argumentation

The AP, via author Beatrice Dupuy, indulges in bot...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee